Pharmalex
Entry
2014
Hold
8yr
Exit
2022
Who owns Pharmalex?
Pharmalex was owned by Auctus Capital Partners through Auctus III (2011 vintage) from 2014 to 2022, exited via Trade Sale.
Buyer identity available on Pro.
Hand-verified · updated 2026-08-10
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2022
More from Auctus III
Other portfolio companies in the same fund.
TimePartner
Exited 2016
Business Services
Germany· 2014
Germany· 2014to
Avedo
Exited 2017
Business ServicesGermany· 2013
Germany· 2013to
Light Metal Casting Solutions Group (StrikoWestofen + ITALPRESSE + Gauss)
Exited 2017
IndustrialsGermany· 2013
Germany· 2013to
unimed
Active
Business ServicesGermany· 2013
Germany· 2013valantic
Exited 2019
IT ServicesGermany· 2013
Germany· 2013to
valantic (formerly Dabero Service Group)
Exited 2019
IT ServicesGermany· 2012
Germany· 2012to
More PE-backed in Pharma
Comparable pharma deals from other GPs.
Laboratoires Delbert
Active
Socadif
France
France
AMW
Active
SHS Gesellschaft für BeteiligungsmanagementGermany· 2026
Germany· 2026Basic Pharma
Active
SHS Gesellschaft für Beteiligungsmanagement
Netherlands· 2026
Netherlands· 2026
Cinclus Pharma
Active
Claret Capital Partners
Sweden· 2026
Sweden· 2026InfoRLife
Active
BC Partners
Switzerland· 2026
Switzerland· 2026
IRAB
Active
ARCHIMED
Spain· 2026
Spain· 2026Track Pharmalex
Save this record to your watchlist and pick up your research where you left off. No spam.
Get the full record on Pharmalex.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue